title: Short-term effects of cardiac steroids on intracellular membrane traffic in neuronal NT2 cells.
abstract: Cardiac steroids (CS) are specific inhibitors of Na+, K+-ATPase activity. Although the presence of CS-like compounds in animal tissues has been established, their physiological role is not clear. In a previous study we showed that in pulse-chase membrane-labeling experiments, long term (hours) interaction of CS at physiological concentrations (nM) with Na+, K+-ATPase, caused changes in endocytosed membrane traffic in human NT2 cells. This was associated with the accumulation of large vesicles adjacent to the nucleus. For this sequence of events to function in the physiological setting, however, CS would be expected to modify membrane traffic upon short term (min) exposure and membrane labeling. We now demonstrate that CS affects membrane traffic also following a short exposure. This was reflected by the CS-induced accumulation of FM1-43 and transferrin in the cells, as well as by changes in their colocalization with Na+, K+-ATPase. We also show that the CS-induced changes in membrane traffic following up to 2 hrs exposure are reversible, whereas longer treatment induces irreversible effects. Based on these observations, we propose that endogenous CS-like compounds are physiological regulators of the recycling of endocytosed membrane proteins and cargo in neuronal cells, and may affect basic mechanisms such as neurotransmitter release and reuptake.
authors.affiliation: The Kuvin Center for the Study of Infectious and Tropical Diseases, Institute of Microbiology, The Hebrew University-Hadassah Medical School, Jerusalem, Israel. hrose@md2.huji.ac.il
authors.forename: H
authors.initials: H
authors.lastname: Rosen
authors.forename: V
authors.initials: V
authors.lastname: Glukmann
authors.forename: T
authors.initials: T
authors.lastname: Feldmann
authors.forename: E
authors.initials: E
authors.lastname: Fridman
authors.forename: D
authors.initials: D
authors.lastname: Lichtstein
mesh_terms: D017209:Apoptosis / Q000187:drug effects / Q000502:physiology*; D001693:Biological Transport, Active; D002018:Bufanolides / Q000378:metabolism* / Q000494:pharmacology; D002301:Cardiac Glycosides / Q000378:metabolism* / Q000494:pharmacology; D002460:Cell Line; D002462:Cell Membrane; D002478:Cells, Cultured; D004077:Digoxin / Q000378:metabolism* / Q000494:pharmacology; D004789:Enzyme Activation; D006801:Humans; D009474:Neurons; D010042:Ouabain / Q000378:metabolism* / Q000494:pharmacology; D015398:Signal Transduction; D000254:Sodium-Potassium-Exchanging ATPase / Q000037:antagonists & inhibitors / Q000378:metabolism*
chemical_list: D002018:Bufanolides; D002301:Cardiac Glycosides; D010042:Ouabain; D004077:Digoxin; C499076:ATP1A1 protein, human; D000254:Sodium-Potassium-Exchanging ATPase; C022777:bufalin